Circulating tumor cells before and during follow-up after breast cancer surgery

  • Authors:
    • Guus van Dalum
    • Gert Jan van der Stam
    • Arjan G.J. Tibbe
    • Bas Franken
    • Walter J.B. Mastboom
    • Ivan Vermes
    • Marco R. de Groot
    • Leon W.M.M. Terstappen
  • View Affiliations

  • Published online on: October 6, 2014     https://doi.org/10.3892/ijo.2014.2694
  • Pages: 407-413
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The presence of circulating tumor cells (CTC) is an independent prognostic factor for progression-free and overall survival for patients with metastatic and newly diagnosed breast cancer. The present study was undertaken to explore whether the presence of CTC before and during follow-up after surgery is associated with recurrence free survival (RFS) and overall survival (OS). In a prospective single center study, CTC were enumerated with the CellSearch system in 30 ml of peripheral blood of 403 stage I-III patients before undergoing surgery for breast cancer (A) and if available 1 week after surgery (B), after adjuvant chemo- and/or radiotherapy or before start of long-term hormonal therapy (C), one (D), two (E) and three (F) years after surgery. Patients were stratified into unfavorable (CTC ≥1) and favorable (CTC=0) prognostic groups. >1 CTC in 30 ml blood was detected in 75/403 (19%) at A, 66/367 (18%) at B, 40/263 (15%) at C, 30/235 (12%) at D, 18/144 (11%) at E and 11/83 (13%) at F. RFS and OS was significantly lower for unfavorable CTC as compared to favorable CTC before surgery (p=0.022 and p=0.006), after adjuvant therapy (p<0.001 and p=0.018) and one (p=0.006 and p=0.013) and two (p<0.001 and p=0.045) years after surgery, but not 1 week post-surgery. The presence of CTC in blood drawn pre and one and two years after surgery, but not post-surgery is associated with shorter RFS and OS for stage I-III breast cancer.
View Figures
View References

Related Articles

Journal Cover

January-2015
Volume 46 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
van Dalum G, van der Stam GJ, Tibbe AG, Franken B, Mastboom WJ, Vermes I, de Groot MR and Terstappen LW: Circulating tumor cells before and during follow-up after breast cancer surgery. Int J Oncol 46: 407-413, 2015.
APA
van Dalum, G., van der Stam, G.J., Tibbe, A.G., Franken, B., Mastboom, W.J., Vermes, I. ... Terstappen, L.W. (2015). Circulating tumor cells before and during follow-up after breast cancer surgery. International Journal of Oncology, 46, 407-413. https://doi.org/10.3892/ijo.2014.2694
MLA
van Dalum, G., van der Stam, G. J., Tibbe, A. G., Franken, B., Mastboom, W. J., Vermes, I., de Groot, M. R., Terstappen, L. W."Circulating tumor cells before and during follow-up after breast cancer surgery". International Journal of Oncology 46.1 (2015): 407-413.
Chicago
van Dalum, G., van der Stam, G. J., Tibbe, A. G., Franken, B., Mastboom, W. J., Vermes, I., de Groot, M. R., Terstappen, L. W."Circulating tumor cells before and during follow-up after breast cancer surgery". International Journal of Oncology 46, no. 1 (2015): 407-413. https://doi.org/10.3892/ijo.2014.2694